MR Assessment of Hepatic Hydatid Disease
NCT03289884 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2018-05-04
Summary
Hydatid disease is a major healthcare problem worldwide caused by infection that commonly affects the liver. Treatments for hydatid disease depend on how advanced the disease is and if the infection is active or not. Currently, doctors decide what stage the disease is at by looking at the appearance of liver on scans and by performing blood tests. It is however still very difficult to be certain if a treatment is working and when is the right moment to start and stop medication. Magnetic Resonance Imaging (MRI) scanning is a safe and non-invasive way of imaging the liver that can provide detailed information not just about what the liver looks like but also other information about the chemical composition of normal and diseased liver tissue. MRI is already widely used in the NHS for many liver conditions but it is unknown whether analysing the chemical composition will help decide on the stage and activity of hydatid liver disease. This study will allow comparison between MRI information about liver structure and composition with existing methods of assessing disease stage. If fluid is later obtained from the liver as part of usual clinical care (either using a needle with ultrasound or at the time of surgery), this study will also compare information about the fluid composition obtained from MRI scanning, with the results obtained when analysing the fluid in the lab. This will help to develop a more accurate way of non-invasively assessing hydatid disease in the liver, in the future.
Conditions
- Cystic Echincoccosis
- Hydatid Disease
Interventions
- OTHER
-
MRI scan (not involving ionising radiation)
The MRI study will be conducted by a trained MR radiographer, supervised by the nominated researcher
- OTHER
-
Ultrasound scan (not involving ionising radiation)
The US scan will be conducted by a nominated researcher
- OTHER
-
Ex vivo MRI scan of cyst fluid sample
The MRI study will be conducted by a trained MR radiographer, supervised by the nominated researcher
- OTHER
-
Aspiration of cyst fluid
For patients undergoing surgery/radiologically guided aspiration the aspiration will be performed by a surgeon (at the Royal Free Hospital) or radiologist
- OTHER
-
Blood test for confirmation of serum IgG levels consistent with hydatid infection
The blood sample will be drawn by a member of the clinical team
Sponsors & Collaborators
-
University College, London
lead OTHER
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-14
- Primary Completion
- 2020-03-01
- Completion
- 2020-03-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Chronic Liver Disease in Urea Cycle Disorders
NCT03721367 ·Status: COMPLETED
-
Noninvasive Tests to Predict the Presence of Esophageal Varices in Patients With Liver Cirrhosis
NCT03513887 ·Status: COMPLETED
-
Changes in gUt micRobiota After Enteral Feeding (in Alcoholic Hepatitis)
NCT04544020 ·Status: COMPLETED
-
Efficacy of Narrow Band Spectrum Endoscopy for the Diagnosis of Gastric Antral Vascular Ectasia in Patients With Liver Cirrhosis
NCT04388150 ·Status: COMPLETED
-
Biomarkers in Liver Failure
NCT02833064 ·Status: ACTIVE_NOT_RECRUITING
-
Phase Ib of Recombinant Human Albumin Injection
NCT04701697 ·Status: COMPLETED ·Phase: PHASE1
-
Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment
NCT03443934 ·Status: COMPLETED
-
Non-Invasive Portal and Hepatic Vein Pressure Estimation
NCT06210178 ·Status: RECRUITING ·Phase: NA
-
Unknown Cause of Acute Liver Failure
NCT02041637 ·Status: COMPLETED
-
hepatomiR cACLD Study
NCT06432582 ·Status: RECRUITING
-
MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis
NCT03438916 ·Status: COMPLETED
-
Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver Diseases
NCT04125654 ·Status: UNKNOWN ·Phase: NA
-
Peritoneal Dialysis Catheters for the Treatment of Refractory Ascites
NCT02975726 ·Status: COMPLETED ·Phase: NA
-
Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation
NCT02084160 ·Status: COMPLETED
-
Serum Autotaxin Levels in Cholestasis of Pregnancy
NCT02480478 ·Status: UNKNOWN
-
Natural History of Advanced Chronic Liver Diseases
NCT07042308 ·Status: RECRUITING
-
HepQuant to Predict Hepatic Encephalopathy After TIPS
NCT04664621 ·Status: WITHDRAWN ·Phase: NA
-
Can MRI Evaluate Beta-blocker Response in Portal Hypertension?
NCT03114813 ·Status: UNKNOWN
-
Clinical,Endoscopic and Radiological Assessment of Portal Hypertension in Children With Chronic Liver Diseases
NCT06097715 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Natural History of Noncirrhotic Portal Hypertension
NCT02417740 ·Status: RECRUITING
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
NCT05205954 ·Status: RECRUITING ·Phase: NA
-
Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPS
NCT03933891 ·Status: UNKNOWN
-
Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network
NCT04251286 ·Status: UNKNOWN
-
Dynamic Liver Tests in Liver Disease
NCT02782247 ·Status: COMPLETED
-
Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.
NCT04311489 ·Status: TERMINATED ·Phase: PHASE2